Conditional approval of medicines by the EMA

Rita Banzi¹, Chiara Gerardi^{2

2}, Vittorio Bertele'², Silvio Garattini²

Affiliations

¹ IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy rita.banzi@marionegri.it.
² IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

Editorial

Rita Banzi et al. BMJ. 2017.

. 2017 May 2:357:j2062.

doi: 10.1136/bmj.j2062.

Rita Banzi¹, Chiara Gerardi^{2

2}, Vittorio Bertele'², Silvio Garattini²

¹ IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy rita.banzi@marionegri.it.
² IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

No abstract available

Conflict of interest statement

Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare.

How productive are NHS consultants?
[No authors listed] [No authors listed] BMJ. 2017 Mar 29;356:j1520. doi: 10.1136/bmj.j1520. BMJ. 2017. PMID: 28356248 No abstract available.